These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 22140134)

  • 1. Angiotensin receptor blockade attenuates glomerulosclerosis progression by promoting VEGF expression and bone marrow-derived cells recruitment.
    Song SM; Wang CC; Qi SH; Xing L; Yang BF; Oite T; Li B
    Nephrol Dial Transplant; 2012 Jul; 27(7):2712-9. PubMed ID: 22140134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local delivery of angiotensin receptor blocker into the kidney ameliorates progression of experimental glomerulonephritis.
    Mahmood J; Khan F; Okada S; Kumagai N; Morioka T; Oite T
    Kidney Int; 2006 Nov; 70(9):1591-8. PubMed ID: 16985512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow cell infusion ameliorates progressive glomerulosclerosis in an experimental rat model.
    Li B; Morioka T; Uchiyama M; Oite T
    Kidney Int; 2006 Jan; 69(2):323-30. PubMed ID: 16408122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin II receptor blocker attenuates overexpression of vascular endothelial growth factor in diabetic podocytes.
    Lee EY; Shim MS; Kim MJ; Hong SY; Shin YG; Chung CH
    Exp Mol Med; 2004 Feb; 36(1):65-70. PubMed ID: 15031673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Met-RANTES reduces endothelial progenitor cell homing to activated (glomerular) endothelium in vitro and in vivo.
    Rookmaaker MB; Verhaar MC; de Boer HC; Goldschmeding R; Joles JA; Koomans HA; Gröne HJ; Rabelink TJ
    Am J Physiol Renal Physiol; 2007 Aug; 293(2):F624-30. PubMed ID: 17567937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impairment of vascular regeneration precedes progressive glomerulosclerosis in anti-Thy 1 glomerulonephritis.
    Wada Y; Morioka T; Oyanagi-Tanaka Y; Yao J; Suzuki Y; Gejyo F; Arakawa M; Oite T
    Kidney Int; 2002 Feb; 61(2):432-43. PubMed ID: 11849383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone-marrow-derived cells contribute to glomerular endothelial repair in experimental glomerulonephritis.
    Rookmaaker MB; Smits AM; Tolboom H; Van 't Wout K; Martens AC; Goldschmeding R; Joles JA; Van Zonneveld AJ; Gröne HJ; Rabelink TJ; Verhaar MC
    Am J Pathol; 2003 Aug; 163(2):553-62. PubMed ID: 12875975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local delivery of angiotensin II receptor blockers into the kidney passively attenuates inflammatory reactions during the early phases of streptozotocin-induced diabetic nephropathy through inhibition of calpain activity.
    Kamal F; Yanakieva-Georgieva N; Piao H; Morioka T; Oite T
    Nephron Exp Nephrol; 2010; 115(3):e69-79. PubMed ID: 20424485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infusion of angiotensin II reduces loss of glomerular capillary area in the early phase of anti-Thy-1.1 nephritis possibly via regulating angiogenesis-associated factors.
    Takazawa Y; Maeshima Y; Kitayama H; Yamamoto Y; Kawachi H; Shimizu F; Matsui H; Sugiyama H; Yamasaki Y; Makino H
    Kidney Int; 2005 Aug; 68(2):704-22. PubMed ID: 16014048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Passive Heymann nephritis: evidence that angiotensin-converting enzyme inhibition reduces proteinuria and retards renal structural injury.
    Zoja C; Corna D; Bruzzi I; Foglieni C; Bertani T; Remuzzi G; Benigni A
    Exp Nephrol; 1996; 4(4):213-21. PubMed ID: 8983642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of intrarenal angiotensin system activation, oxidative stress, inflammation, and impaired nuclear factor-erythroid-2-related factor 2 activity in the progression of focal glomerulosclerosis.
    Kim HJ; Sato T; Rodríguez-Iturbe B; Vaziri ND
    J Pharmacol Exp Ther; 2011 Jun; 337(3):583-90. PubMed ID: 21357516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of valsartan on the renal vascular endothelial growth factor and its receptor flk-1 of diabetic rats].
    Tang WX; Chen ZJ; Huang SM; Tao Y; Fu P
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Mar; 39(2):223-6, 230. PubMed ID: 18630688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow cells contribute to regeneration of damaged glomerular endothelial cells.
    Ikarashi K; Li B; Suwa M; Kawamura K; Morioka T; Yao J; Khan F; Uchiyama M; Oite T
    Kidney Int; 2005 May; 67(5):1925-33. PubMed ID: 15840040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelial growth factor165 resolves glomerular inflammation and accelerates glomerular capillary repair in rat anti-glomerular basement membrane glomerulonephritis.
    Shimizu A; Masuda Y; Mori T; Kitamura H; Ishizaki M; Sugisaki Y; Fukuda Y
    J Am Soc Nephrol; 2004 Oct; 15(10):2655-65. PubMed ID: 15466270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II type I receptor blockade suppresses glomerular renin-angiotensin system activation, oxidative stress, and progressive glomerular injury in rat anti-glomerular basement membrane glomerulonephritis.
    Kinoshita Y; Kondo S; Urushihara M; Suga K; Matsuura S; Takamatsu M; Shimizu M; Nishiyama A; Kawachi H; Kagami S
    Transl Res; 2011 Oct; 158(4):235-48. PubMed ID: 21925120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Podocyte foot process broadening in experimental diabetic nephropathy: amelioration with renin-angiotensin blockade.
    Mifsud SA; Allen TJ; Bertram JF; Hulthen UL; Kelly DJ; Cooper ME; Wilkinson-Berka JL; Gilbert RE
    Diabetologia; 2001 Jul; 44(7):878-82. PubMed ID: 11508273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects on protein kinase C-beta inhibition on glomerular vascular endothelial growth factor expression and endothelial cells in advanced experimental diabetic nephropathy.
    Kelly DJ; Buck D; Cox AJ; Zhang Y; Gilbert RE
    Am J Physiol Renal Physiol; 2007 Aug; 293(2):F565-74. PubMed ID: 17522264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway.
    Nagai N; Izumi-Nagai K; Oike Y; Koto T; Satofuka S; Ozawa Y; Yamashiro K; Inoue M; Tsubota K; Umezawa K; Ishida S
    Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4342-50. PubMed ID: 17724226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renoprotective effects of valsartan and enalapril in STZ-induced diabetes in rats.
    Kalender B; Oztürk M; Tunçdemir M; Uysal O; Dagistanli FK; Yegenaga I; Erek E
    Acta Histochem; 2002; 104(2):123-30. PubMed ID: 12086332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-inflammatory effects of AT1 receptor blockade provide end-organ protection in stroke-prone rats independently from blood pressure fall.
    Sironi L; Gelosa P; Guerrini U; Banfi C; Crippa V; Brioschi M; Gianazza E; Nobili E; Gianella A; de Gasparo M; Tremoli E
    J Pharmacol Exp Ther; 2004 Dec; 311(3):989-95. PubMed ID: 15302895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.